You just read:

To Lead the Field of ALS Treatment Worldwide: Kadimastem Announces Strategic Collaboration with Korean Biotech Company Corestem, Including a $7M Investment in Kadimastem

News provided by

Kadimastem

Dec 07, 2016, 09:00 ET